Lifecore Biomedical, Inc (LCBM) reported net sales totaling $15.7 million for the first quarter ended September 30, 2007. This net sales figure represents an increase of 5 percent over net sales that totaled $15.0 million during the first quarter of … Continue reading →

EpiCept Corporation’s Senior Director of Lead Discovery, Dr. John Drewe, will present at the IBC at the Hotel Del Coronado in San Diego, CA on October 17, 2007. During this presentation, Dr. Drewe will describe the advances into pre-clinical testing … Continue reading →

Chase Corporation (AMEX:CCF) reported revenue of $127.5 million for the fiscal year ended August 31, 2007. The newly reported revenue represents an 18% increase over revenues that totaled $108.4 million during the previous fiscal year. Additionally, net income for the … Continue reading →

Ballantyne of Omaha, Inc. (Amex: BTN), a leading motion picture projection, digital cinema and lighting equipment provider, announced that it has completed the purchase of privately-held Marcel Desrochers, Inc. (MDI). Marcel Desrochers is a respected manufacturer of cinema projection screens, … Continue reading →

According to a recent study published by HealthGrades (HGRD), Patients have on average a 71 percent lower chance of dying at the nation’s top-rated hospitals compared with the lowest-rated hospitals during 18 common procedures and conditions. These procedures ranged from … Continue reading →

Equity Media Holdings Corporation (EMDA) announced that its wholly owned subsidiary, Retro Television Network [RTN], plans to add third affiliate on their El Paso, Texas television station. The network will launch in 2008 on a digital stream of KFOX-TV, the … Continue reading →

IMAX Corporation (IMAX) reported earlier today that Catalyst Fund Limited Partnership II has officially withdrawn their pertinent lawsuit against the company. Catalyst was seeking to invalidate the general consent that was reached in the company deciding to extend the filing … Continue reading →

Hemispherx Biopharma announced today that it has filed a new drug application with the U.S. Food and Drug Administration for its experimental therapeutic which is designed to treat Chronic Fatigue Syndrome. The company also announced that it is moving forward … Continue reading →

DARA Bioscences, a privately held development-stage pharmaceutical company, announced that they have entered into a definitive agreement to merge with Point Therapeutics (POTP). Per this agreement, DARA will merge into one wholly owned subsidiary of Point Therapeutics. This agreement also … Continue reading →

Onstream Media Corporation (ONSM), a leading online service provider for digital media, announced early Wednesday that they are ready to upgrade their already popular Visual Webcaster service. The companies video broadcast upgrade will include utilizing the industry standard 16:9 aspect … Continue reading →